Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses.
about
Anti-inflammatory and immunoregulatory functions of artemisinin and its derivativesArtesunate abolishes germinal center B cells and inhibits autoimmune arthritisEthyl Caffeate Ameliorates Collagen-Induced Arthritis by Suppressing Th1 Immune Response.Naja naja atra Venom Protects against Manifestations of Systemic Lupus Erythematosus in MRL/lpr MiceSM934 treated lupus-prone NZB × NZW F1 mice by enhancing macrophage interleukin-10 production and suppressing pathogenic T cell development.Baicalin, a natural compound, promotes regulatory T cell differentiation.Galectin-9 ameliorates clinical severity of MRL/lpr lupus-prone mice by inducing plasma cell apoptosis independently of Tim-3.Artemisinin analogue SM934 ameliorates murine experimental autoimmune encephalomyelitis through enhancing the expansion and functions of regulatory T cell.Artemisinin analogue SM934 ameliorates the proteinuria and renal fibrosis in rat experimental membranous nephropathy.Decrease of Functional Activated T and B Cells and Treatment of Glomerulonephitis in Lupus-Prone Mice Using a Natural Flavonoid AstilbinToll-like receptors: potential targets for lupus treatmentMetabolic regulation of organelle homeostasis in lupus T cellsTherapeutic effects of DZ2002, a reversible SAHH inhibitor, on lupus-prone NZB×NZW F1 mice via interference with TLR-mediated APC response.Early IL-17 production by intrahepatic T cells is important for adaptive immune responses in viral hepatitisCutting edge: Leptin-induced RORγt expression in CD4+ T cells promotes Th17 responses in systemic lupus erythematosus.Development of Th17-Associated Interstitial Kidney Inflammation in Lupus-Prone Mice Lacking the Gene Encoding STAT-1.Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation.Artemisinin analogue SM934 attenuate collagen-induced arthritis by suppressing T follicular helper cells and T helper 17 cells.Mycophenolic acid derivative 118 improves outcome of skin grafts by suppressing IL-17 production.Qinghaosu (artemisinin): chemistry and pharmacology.Therapeutic potential of interleukin-17 in inflammation and autoimmune diseases.Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics.Immune suppressive properties of artemisinin family drugs.Humulus scandens exhibits immunosuppressive effects in vitro and in vivo by suppressing CD4(+) T cell activation.Human Umbilical Cord Mesenchymal Stem Cells Inhibit T Follicular Helper Cell Expansion Through the Activation of iNOS in Lupus-Prone B6.MRL-Faslpr Mice.Water-soluble artemisinin derivatives as promising therapeutic immunosuppressants of autoimmune diseases.Natural Modulators of Endosomal Toll-Like Receptor-Mediated Psoriatic Skin Inflammation.Suppression of interleukin 17 contributes to the immunomodulatory effects of adipose-derived stem cells in a murine model of systemic lupus erythematosus.Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus.
P2860
Q28083774-7A0B9089-ED36-450F-8501-9A7E415EF588Q28541811-0EFAE6A6-33F5-4F49-8F4E-4EF31D1CF4E4Q33863687-504F6CCD-49EE-4BC2-B1EE-0DBDCE7E6449Q33908254-04A7778E-888B-4404-B0FF-FCC9794F8448Q34184574-DE8BF4BA-3591-4BBA-9804-76392A8ADA11Q34271668-2B638358-E5BA-46BF-A1B7-C28A78145B94Q34667834-7A34D3A3-B1C9-4860-AAC3-2C152F7CB4B3Q34979858-7ADE7400-6D5C-4000-AF86-94A17033A989Q35080166-146DD6DB-5FD3-42FD-8173-4415C9E5BAF1Q35389559-BA55CDBD-7E1D-400F-8B7D-BC51F17B992FQ35848152-699DBBB9-3FC0-412F-97CB-31F90ADB33CFQ36177195-3DE588A8-F517-4DFD-8EED-F1141B5697F5Q36295343-2F92F5D9-316C-4DFF-8ED3-30C3740F2837Q36514100-379E9FE3-13ED-4C2B-BC49-43B891A64CFCQ36718109-6B420068-C9F7-414C-B494-D01D7B6B3873Q36844749-D86A417D-F908-446E-86EF-ACD74DA0A552Q36870048-65F42458-0DD8-4CF8-86C5-1B305F416ACEQ37449374-04B3E0E4-E4FC-4799-B0B4-75D9BE790DABQ37728508-2CD0DA35-777F-4597-8314-3AA5CFBE3B2AQ37729457-28BFBF25-3E16-4DFE-A9FA-841AF38B5513Q38154628-A6AEFDB2-4114-4A79-A5CA-0850BC4D848BQ38557048-16033519-1EB6-4C92-BDD2-6C0504031782Q38895489-FD257AB2-590D-44EC-A8B3-9C56020F4B65Q42207416-07EFEBD9-6430-4336-AA0C-3469008BE3C8Q47147527-A53CD55B-4C8F-4F2B-AABD-C03E737A3EAAQ47892736-FE4CD554-9D32-4BF6-8ABF-6F74D2A66672Q48089641-523BB4C3-876C-4D8C-9D87-71C17DD8EFC4Q51519261-49FF899D-8CD1-4DB5-9054-3601E5F25BC0Q52867190-5BE4505B-26F3-44D8-8362-A0F839DB2FB1
P2860
Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Oral administration of artemis ...... g Th1 and Th17 cell responses.
@en
Oral administration of artemis ...... g Th1 and Th17 cell responses.
@nl
type
label
Oral administration of artemis ...... g Th1 and Th17 cell responses.
@en
Oral administration of artemis ...... g Th1 and Th17 cell responses.
@nl
prefLabel
Oral administration of artemis ...... g Th1 and Th17 cell responses.
@en
Oral administration of artemis ...... g Th1 and Th17 cell responses.
@nl
P2093
P2860
P356
P1476
Oral administration of artemis ...... ng Th1 and Th17 cell responses
@en
P2093
Feng-Hua Zhu
Jian-Ping Zuo
Pei-Lan He
Shi-Jun He
Yi-Fu Yang
P2860
P304
P356
10.1002/ART.30392
P50
P577
2011-08-01T00:00:00Z